10. BPH Prostate Ca.pptx sinks one studying

sikombeivwananji89 90 views 33 slides May 02, 2024
Slide 1
Slide 1 of 33
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33

About This Presentation

It's very helpful to all medical assistants and students


Slide Content

“BPH” Cafterm’s Lecture notes

PATTERN OF UROLOGY

ANATOMY It is an accessory gland of male reproductive system. It is composed of glandular tissue embedded in fibromuscular stroma. McNeal Divided Prostate into Three Zones • Peripheral zone – prone for carcinoma. • Periurethral transition zone where BPH arises. • Central zone .

ANATOMY

PROSTATE GLAND Bladder neck pyramidal in shape. Measures 4X3X2cm 10-20gm Zones Mc Neil 1972

Mcneal McNeal Divided Prostate into Three Zones • Peripheral zone – prone for carcinoma. • Periurethral transition zone where BPH arises. • Central zone -25% glandular tissue and contains ejaculatory ducts with prostatic urethra

PROSTATE Prostatic vessels inferior vesical Valvless veins Batson (3 and 9 O clock) Prostate capsule Denonvilliers Fascia

PROSTATE SPECIFIC ANTIGEN (PSA) It is a protease, produced from the prostatic epithelium secreted in the semen to cleave and liquefy the seminal coagulum formed after ejaculation. PSA is organ specific. Normal value is 4 ng/ml of plasma . More than 10 ng/ml is significant .

Benign Prostatic Hyperplasia (BPH) It is benign enlargement of prostate which occurs after 50 years, usually between 60 and 70 years.

Etiology: Unknown but theories: (1) Hormonal dependent theory : (Role of Androgen) testosterone →5 α- reductase enzyme → 5 DHT → ↑ growth factors → enlargement. (2) Role of estrogen: (Hormonal imbalance) there's associated ↑ of serum estrogen. (↑ E / T Ratio) (3) Programmed cell death regulation: (Apoptosis) ↓ apoptosis (↑ cell growth ) (4) Neoplastic theory: BPH is considered as Bg tumor.

Lower urinary tract symptoms (LUTS) Symptoms of voiding • Hesitancy • Intermittent stream –stops and starts Poor flow (not improving by straining) • Dribbling even after micturition Incomplete emptying Dysuria

Cont ’ Symptoms of storage Frequency Urgency Nocturia Urge incontinence

DRE (Digital Rectal Examination): Prostate size & contour can be assessed (5S) Symmetrically enlarged, Smooth surface, Soft to firm, preserved Sulci, Sliding rectal mucosa over it ) - feel anterior wall of the rectum which lies along posterior prostate -enlarged hard nodules could be prostate cancer

Complications. Recurrent hematuria Renal stones Recurrent urinary tract infection Renal failure Retention (acute and chronic) The above are also indications for prostatectomy

Investigations: Laboratory : Urine analysis. L iver & kidney function. Urine MCS. PSA (prostate specific Ag) 2. Urodynamic study ( Uroflowmetry ) Q max (peak) = normal > 15 ml / sec. < 10 ml / sec means obstruction to bladder outflow.

Cont ’ 3. Imaging: TRUS . (Trans-rectal ultrasound) MRI . IVU : (intravenous urogram) to show back pressure on the kidney . 4. BIOPSY Core needle biopsy

Treatment: Prophylaxis : avoid ppt factor e.g. Excess work, worry, weather (cold), wine, women, withholding urine in bladder, spices, constipation . 2. Medical therapy: α 1 - blockers: e.g. Tamsulosin , Alfuzosin . block α- receptors in the urethra → ↓ its tone. 5α- reductase inhibitors: e.g. Finasteride resulting into shrinking of the prostate by converting testosterone to dihydrotestosterone

3. SURGICAL MANAGEMENT Intra prostatic stent Balloon dilatation TURP-Trans Urethral resection of the prostate Trans urethral vaporization Trans urethral incision Open prostatectomy Laser

Complications of surgery in BPH Bleeding Urethral stricture Urinary incontinence Erectile dysfunction Retrograde ejaculation

Conditions associated with raised PSA Prostate cancer BPH Prostatitis UTI Ejaculation Medical procedures Digital rectal examination

THANK YOU Cafterm’s Lecture notes

PROSTATE CANCER Cafterm’s Lecture notes

Prostate cancer Prostate cancer is the carcinoma of gland that may spread to other parts of the body particularly bones and lymph nodes.

RISK FACTORS Obesity Age Family history Low levels of vitamin D Prostatitis Elevated blood levels of testosterone Occupational exposure to chemicals Family history Alcohol & smoking

Symptoms Weak or interrupted urine flow Hematuria Nocturia Dysuria Pain in pelvis, spine and ribs Lymphedema Blood in semen ( hematospermia ) Painful ejaculation

History Symptoms Late Backache-central back pain Hematospermia LUTS Weight loss

Examination DRE Prostate firm to hard, Maybe nodular, Mucosa adherent to prostate Usually enlarged gland Median sulcus obliterated +/- blood gloved finger

Grading: According to Gleason score (0-10) 2-4 ‘n well differentiated tumour 5-7 ‘n moderately differentiated 8-10 ‘n undifferentiated tumour

Histological Subtypes of Prostate Ca Atrophic Sarcomatoid Signet ring like cell Pleomorphic giant cell Foamy gland Mucinous Pseoudohyperplastic

Diagnostic parameters 1. PSA -PSA greater than 10ng/ml 2. DRE : useful in ruling out prostate enlargement caused by benign prostatic hyperplasia 3. PROSTATE BIOPSY 4. MRI/CT SCAN: to assess the extension into the bladder and lymph nodes for staging the cancer and to evaluate bone metastasis.

Treatment 1. prostatectomy: removal of prostate gland 2. radiotherapy: radiation directed towards the whole pelvis 3. hormone therapy; 4. anti-androgens 5. chemotheapy

C omplications Hemorrhage Hypovolemic shock Infection Pulmonary embolism Sexual dysfunction